Skip to main content Back to Top
Advertisement

7/10/2017

Levocarnitine Oral Tablets and Solution

Reason for the Shortage

    • Akorn has levocarnitine tablets and oral solution available.
    • Sigma-Tau had Carnitor presentations on shortage due to increased demand.
    • Rising Pharmaceuticals discontinued levocarnitine tablets in January 2017.

Available Products

    • Carnitor oral solution, Sigma-Tau, 100 mg/mL, 118 mL bottle, 24 count, NDC 54482-0145-08
    • Carnitor SF Sugar-Free oral solution, Sigma-Tau, 100 mg/mL, 118 mL bottle, 24 count, NDC 54482-0148-01
    • Levocarnitine oral solution, Akorn, 100 mg/mL, 118 mL bottle, 24 count, NDC 50383-0171-04
    • Levocarnitine oral solution, Rising Pharmaceuticals, 100 mg/mL, 118 mL bottle, 24 count, NDC 64980-0503-12
    • Carnitor oral tablet, Sigma-Tau, 330 mg, unit-dose blister pack, 90 count, NDC 54482-0144-07
    • Levocarnitine oral tablet, Akorn, 330 mg, unit-dose blister pack, 90 count, NDC 50383-0172-90

Updated

Updated July 10, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Created November 1, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins